506 Phase (Ph) 1/2a study of TSR-011, a potent inhibitor of...

European Journal of Cancer 2014 / 11 Vol. 50

506 Phase (Ph) 1/2a study of TSR-011, a potent inhibitor of ALK and TRK, in advanced solid tumors including crizotinib-resistant ALK positive non-small cell lung cancer

Sachdev, J., Arkenau, H.T., Infante, J.R., Mita, M.M., Anthony, S.P., Natale, R.B., Ejadi, S., Wilcoxen, K., Kansra, V., Laken, H., Hughes, L., Martell, R., Weiss, G.J.
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
50
Language:
english
Journal:
European Journal of Cancer
DOI:
10.1016/S0959-8049(14)70632-X
Date:
November, 2014
File:
PDF, 59 KB
english, 2014
Conversion to is in progress
Conversion to is failed